Mandatory notification of trade

19 Feb 2026 10:21 CET

Moss, 19 February 2026

Gentian Diagnostics ASA ("Gentian") has today been notified that the following
transaction has been completed by a primary insider in Gentian:

Frank Frantzen, CTO and primary insider in Gentian, has purchased 3,115 shares
in Gentian at NOK 40.00 per share. Mr. Frantzen owns 23,115 shares and 50,000
options after this transaction.


PDMR notification pursuant to the EU Market Abuse Regulation Article 19 is
attached.

This information is subject to the disclosure requirements pursuant to Section
5-12 of the Norwegian Securities Trading Act, EU Market Abuse Regulation Article
19 and Euronext Oslo Rule Book II.

For further information, please contact: Njaal Kind, Group CFO,
njaal.kind@gentian.no, +47 91 90 65 25

More information:
Access the news on Oslo Bors NewsWeb site

666196_2026 02 19 Frank Frantzen KRT-1500.pdf